 | • レポートコード：MRC2108A361 • 出版社/出版日：Mordor Intelligence / 2021年7月31日 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社は、非侵襲美容治療の世界市場規模が2021年から2026年の間に12％成長すると予測しています。本調査資料では、世界の非侵襲美容治療市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、用途別（血小板機能障害、血友病、血小板減少症、周術期疾患）分析、エンドユーザー別（病院、外来手術センター、その他）分析、地域別分析（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）、競争状況、市場機会/将来の見通しなどを掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・非侵襲美容治療の世界市場規模：用途別（血小板機能障害、血友病、血小板減少症、周術期疾患） ・非侵襲美容治療の世界市場規模：エンドユーザー別（病院、外来手術センター、その他） ・非侵襲美容治療の世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（The American National Red Cross、America's Blood Centers、Blood Centers of America、American Association of Blood Banks( AABB)、Canadian Blood Services、Cellphire, Inc.、The European Blood Alliance、DRK-Blutspendedienst Nord-Ost gemeinnützige GmbH、OneBlood、Megakaryon Corporation、PlateletBio） ・市場機会/将来の見通し |
The global non-invasive aesthetic treatment market is expected to register a CAGR of 12% during the forecast period of 2021-2026.
The COVID-19 pandemic impacted the non-invasive aesthetic treatment market negatively as the world went into quick lockdown to stop the spread of the infection due to the virus. The footfall of the people seeking aesthetics treatment reduced at hospitals, clinics, and other places which offer the services. Also, the scheduled procedures were either canceled or postponed which impacted the market. For instance, as per the survey conducted in March 2020 by Hamilton Fraser Cosmetics Insurance in the United Kingdom on over 1,360 cosmetics practitioners, about 99.8% of practitioners stated that their practice has been affected by the ongoing COVID-19 pandemic. Moreover, the COVID-19 pandemic also provided an opportunity to the companies to enhance their homecare non-invasive aesthetics products and services, as in the later phase of the pandemic it was observed that there was an increase in the number of people seeking aesthetic treatments due to the work from a home scenario which may augment the market growth in coming years.
As the digital world is moving forward with so many social media and other application, the demand of beauty products have risen sharply in last few years as well as increase in the demand of non-invasive aesthetic treatment procedures for the beauty enhancement, which is the major driving factor behind the high growth rate of the studied market. Over the year, popularity of non-invasive aesthetic treatment methods gained traction because it involves scarless and quick treatment procedures as compared to other beauty enhancement procedures. For instance, as per the 2020 report of the American Society of Plastic Surgeons, the total minimally invasive cosmetic procedures conducted in the United States in 2020 was about 13,281,235 of which botulinum toxin type procedure were 4,401,536.
Other factors that will complement the growth of the non-invasive aesthetic treatment market during the forecast period are the technological advancement and launch of new products in the area, and its awareness in the old age people which represent a fare share of world population. For instance, in August 2020, Lumenis Ltd launched a new device for non-invasive treatment devices for personalized non-invasive radio frequency (RF) treatments according to the requirement of every patient, the device is called NuEra Tight.
The availability of low-cost beauty products in the market and complications and risks associated with the aesthetic treatment methods are the major restraining factor for the non-invasive aesthetic treatment market as the other beauty products are cheap and readily available as compared to specialized non-invasive treatments, while the risks associated with the procedures creates fear and misconceptions among the potential user.
Key Market Trends
Injectable Segment is Expected to Occupy a Significant Market Share Over the Forecast Period
In terms of procedure, the injectable segment is expected to occupy a significant market share in the forecast period as compared to other procedures like skin rejuvenation, non-surgical fat removal, etc. As compared to other available options in the injectable segment, the botulinum toxin (most commonly known as Botox) market is increasing very rapidly and is the most widely used injectable in non-invasive beauty enhancement procedures all over the world. As per a 2019 report by the International Society of Aesthetic Plastic Surgery, there were 6,271,488 botulinum toxin procedures done globally constituting 46.1% of the total non-invasive procedures.
The other factors complementing the growth of the injectables market are new research and developments in the area and the launch of a new and advanced solution by the key market players in the area who are actively working towards bringing improvement in the non-invasive aesthetic treatment market. For example, in June 2021, the United States Food and Drug Administration provided its approval to Galderma’s Restylane Contour for improving cheek augmentation and midface contour deficiencies. In January, 2020, Allergan facility in the Mayo town of Westport shipped the 100 millionth vial of Botox. The Westport facility is responsible for manufacturing the global supply of the anti-wrinkle, injection treatment as the company marked 30 years since the product first received approval.
North America is Expected to Dominate the Non-Invasive Aesthetic Treatment Market during the Forecast Period
North America is expected to dominate the market of non-invasive aesthetic treatment during the forecast period mainly due to the increasing demand for beauty-enhancing procedures and the availability of a handful of resources in the region. Among all, the United States will be the largest market in the North American region for the studied market. According to the 2020 report of the American Society of Plastic Surgeons, Americans have a more positive opinion towards plastic surgery or non-surgical procedures than before the COVID-19 pandemic. It also reported that about 11% of the surveyed women were interested in getting either surgical or non-surgical cosmetics procedures, the number was higher in the women who already had surgery or any kind of cosmetic procedure, about 24%.
As per the 2020 report of the International Society of Aesthetic Plastic Surgery, in 2019 the United States and Mexico were two of the top 10 countries where most cosmetic surgeries and procedures (both surgical and non-surgical) were performed. As per the International Society of Aesthetic Plastic Surgery (ISAPS) Report, 2019, the total number of botulinum A procedures that were performed accounted to 287,420 constituting 46.4% of nonsurgical procedures in Mexico.
The major reason was the increasing popularity of the aesthetic treatment in the region for beauty enhancement in both adults and old age population. Also, the presence of few of the key market leaders in the region augments the growth of the market as they promote their products via different sources and provides better services in the region. For example, in October 2020, BTL Aesthetics announced the launch of the EMSCULPT NEO for non-invasive procedure in the removal of fat cells and treating body contouring.
Thus, above factors will contribute to the growth of non-invasive aesthetic treatment market in the region along with its dominance in the market.
Competitive Landscape
The non-invasive aesthetic treatment market is getting very competitive due to the increase in the number of companies in the area as well as established market players who are also bidding for the market share. For example, the acquisition of Allergan by AbbVie in 2020. Some of the key companies for the market of non-invasive aesthetic treatment are Galderma, Alma Lasers, Hologic Inc., AbbVi, Inc., Merz Pharma, Lumenis, and others.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Number of Surgical Procedures
4.2.2 Increasing Prevalence of Chronic and Blood-related Disorders
4.3 Market Restraints
4.3.1 High Cost and Risk of Infections in Transfusion Procedure
4.3.2 Shortage of Blood Donors
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Applications
5.1.1 Platelet Function Disorders
5.1.2 Hemophilia
5.1.3 Thrombocytopenia
5.1.4 Perioperative Indications
5.2 End User
5.2.1 Hospitals
5.2.2 Ambulatory Surgical Centers
5.2.3 Other end-users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 The American National Red Cross
6.1.2 America’s Blood Centers
6.1.3 Blood Centers of America
6.1.4 American Association of Blood Banks( AABB)
6.1.5 Canadian Blood Services
6.1.6 Cellphire, Inc.
6.1.7 The European Blood Alliance
6.1.8 DRK-Blutspendedienst Nord-Ost gemeinnützige GmbH
6.1.9 OneBlood
6.1.10 Megakaryon Corporation
6.1.11 PlateletBio
7 MARKET OPPORTUNITIES AND FUTURE TRENDS